A Study of CSTI-500 in Patients With Prader-Willi Syndrome

Clinical trial NCT07348601 · RECRUITING

Trial details

NCT number: NCT07348601
Sponsor: ConSynance Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prader-Willi Syndrome

Start date: 2026-05-01
Primary completion: 2027-06-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.